Ethical Obligations and Genetic Screening
This blog discusses how OB/GYNs need not only to understand the science behind genetic screening but also to counsel patients properly about the results.
Cell-Free DNA Screening for Trisomy 21
Cell-free fetal DNA screening tests for trisomy 21 are more accurate than standard screening with nuchal translucency even in low-risk women.
Interpreting Failed Results on NIPT
SMFM 2015: A failed result on noninvasive prenatal testing (NIPT) may provide insight into what subsequent tests may find, research reveals.
5 Predictions for Prenatal Genetic Testing in 2015
These 5 predictions by Adam Wolfberg, MD, provide insight into how genetic testing—NIPT to microarray and cost to quality—continues to evolve.
Tips for Navigating Prenatal Genetic Testing
Amniocentesis, CVS, noninvasive prenatal testing, microarray . . . the rapid advancements in prenatal genetic testing can be dizzying. These 7 expert tips can help navigate the gamut.
The Genetics of Preterm Birth: True Labor or False Labor?
New research may have found a way to better predict whether women with threatened preterm labor are in true labor or false labor.
The Most Hotly Anticipated Ob/Gyn Research of 2014
New research expected this year will bring about significant changes to clinical practice. Here, society leaders share what’s on their radar for 2014.
The Leadership Report: The Best Ob/Gyn Research from 2013
What research from the past year will have the most significant impact on women's health care? The leaders of five major ob/gyn societies weigh in.
Noninvasive Prenatal Testing Detects Most Chromosomal Abnormalities
New research presented at The Pregnancy Meeting™ last week in New Orleans shows that noninvasive prenatal testing can detect more than 80% of chromosomal abnormalities.
The Ethical Ob/Gyn: Designing Babies
The ethical issues between two new technologies are stark. One aims to cure disease, whereas the other threatens to alter fundamentally the parent-child relationship.